ACE2 and acute respiratory distress syndrome: Recombinant human ACE2 (rhACE2) is one such drug; rhACE2 is successfully making its way into human trials for conditions such as acute respiratory distress syndrome (ARDS) and heart failure, but its hepatic effects are ill defined given scarcity of studies [30,155,156].